Bledea et al. dissected methylation data from IDH mutant CCA (GSE124617) [91], and their results support the suggestion that hypermethylation of enhancers associated with cell differentiation may mediate lack of differentiation in IDH1/2 mutant cancers. Here, IDH2 is linked to cholangiocarcinoma.